Following reports of shortages of 300mg lamivudine tablets, the Department of Health has assured the public there is no stock out of the antiretroviral (ARV) and issued clinician guidance regarding the formulation, which will no longer be offered on tender.
Read More »No ARV shortage – Department of HealthAfter months of erratic supply of its antiretroviral (ARV) Aluvia in South Africa, international pharmaceutical company AbbVie will now allow generic manufacturers to produce the drug to help safeguard supplies, according to an announcement made today.
Read More »New agreement could help end ARV stock outsThere is an almighty struggle to get affordable, appropriate medicine for TB – particularly when one tablet to treat drug-resistant TB can cost R655.
Read More »Strawberry flavours and excessive pricesActivists stormed representatives of the French multinational pharmaceutical company Sanofi at the World Lung Health Conference. Organisations including the Treatment Action Campaign (TAC) have accused the company of profiteering and charging South Africans up to almost ten times the global price for a much needed medicine to treat drug-resistant tuberculosis (TB).
Read More »Protestors slam Sanofi for allegedly raising costs of medicines in SAFrom your pet cat to the lions of the Kruger Park, animal carriers of tuberculosis (TB) are becoming an increasing concern as research continues to reveal TB in the most surprising of places.
Read More »Fluffy could give you TBMore than 300 former tuberculosis (TB) patients, activists and health experts have demanded that countries like China, Brazil and India increase TB research funding as the bacteria continues to hundreds of thousands of their citizens in the ground each year.
Read More »Protesters demand BRICS triple TB research fundingMore than 30,000 children develop tuberculosis (TB) each year in South Africa. For these children, cure comes in the form of six months of daily, bitter pills made for adults more than twice their size but new, better treatment may be on the way, according to research non-profit the TB Alliance.
Read More »World debuts new combination TB drug for childrenFour South African research institutions are among the top 100 funders of tuberculosis (TB) research in the world according to a new report released today. If the country could triple TB research funding in the next three years, it could even outstrip richer countries.
Read More »South Africa among world’s top TB fundersNo one knows how many South Africans are living with hepatitis C but the virus affects everyone from injecting drug users to suburban housewives. For decades, Hep C treatment was priced out of reach. Now, South Africa is importing new, better and cheaper drugs but a cure still comes at a cost.
Read More »South Africa’s ‘other’ virusThe Treatment Action Campaign (TAC) has received a R14 million pledge from Canadian non-profit organisation the Stephen Lewis Foundation that will save it from closing its doors, but will not save jobs already on the cutting board.
Read More »Treatment Action Campaign receives R14mIn an effort to combat medicine shortages, South Africa will roll out a first of its kind early warning system to identify drug stock outs before they happen. See what else the country is doing to keep pills in patients’ hands.
Read More »4 things South Africa is doing to safeguard medicinesIn an effort to combat medicine shortages, South Africa will roll out a first of its kind early warning system to identify drug stock outs before they happen. The move comes as country and makers of the antiretroviral Aluvia work to address shortages
Read More »South Africa launches world’s first early drug stock out warning systemFrom the Eastern Cape to Limpopo, medicine shortages continue to be reported throughout South Africa. In a year in which it seems stock outs have become the new mystery disease, the causes shortages remain difficult to diagnose.
Read More »Medicine shortages: A hard diagnosisA civil society inquiry has accused the Free State of failing to act on alleged shortages of medicine, health professionals and ambulances. The Free State says the inquiry is politically motivated.
Read More »Free State ‘fails to act against shortage of drugs, doctors’More than half of all young South Africans live in poverty, according to a new report released today. The report is a stark reminder that not even the “born free” generation is free of poverty’s shackles.
Read More »The chance of our birth